Parul Trivedi1, Peiman Hematti. 1. Department of Medicine, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, WI, USA.
Abstract
OBJECTIVE: Human embryonic stem cells (hESCs) have been shown to generate CD34(+) primitive hematopoietic cells after several days of coculturing with the OP9 murine stromal cell line. CD73(+) multipotent mesenchymal cells have also been isolated from hESC/OP9 cocultures after several weeks. We hypothesized that generation of CD34(+) hematopoietic cells and CD73(+) mesenchymal stem cells (MSCs) may follow similar kinetics, so we investigated the generation of CD73(+) cells in the first 2 weeks of hESC/OP9 cocultures, at a time when CD34(+) cells are generated. MATERIALS AND METHODS: We cocultured hESCs with OP9 cells and examined the time course of appearance of human CD34(+) and CD73(+) cells using flow cytometry. We tested the hematopoietic progenitor potentials of CD34(+) cells generated using hematopoietic colony-forming assays, and the multipotent mesenchymal properties of CD73(+) cells generated using in vitro differentiation assays. RESULTS: We observed that in the first 2 weeks of the hESC/OP9 coculture system CD34(+) hematopoietic and CD73(+) MSC generation follows a similar pattern. We sorted the CD34(+) cells and showed that they can generate hematopoietic progenitor colonies. Starting with cocultured cells on day 8, and through an enrichment procedure, we also could generate a pure population of MSCs. These hESC-derived MSCs had typical morphological and cell surface marker characteristics of adult bone marrow-derived MSCs, and could be differentiated toward osteogenic, adipogenic, and chondrogenic cells in vitro, a hallmark property of MSCs. CONCLUSIONS: OP9 cells when cocultured with hESCs support simultaneous generation of CD34(+) primitive hematopoietic cells and CD73(+) MSCs from hESCs.
OBJECTIVE:Human embryonic stem cells (hESCs) have been shown to generate CD34(+) primitive hematopoietic cells after several days of coculturing with the OP9 murine stromal cell line. CD73(+) multipotent mesenchymal cells have also been isolated from hESC/OP9 cocultures after several weeks. We hypothesized that generation of CD34(+) hematopoietic cells and CD73(+) mesenchymal stem cells (MSCs) may follow similar kinetics, so we investigated the generation of CD73(+) cells in the first 2 weeks of hESC/OP9 cocultures, at a time when CD34(+) cells are generated. MATERIALS AND METHODS: We cocultured hESCs with OP9 cells and examined the time course of appearance of humanCD34(+) and CD73(+) cells using flow cytometry. We tested the hematopoietic progenitor potentials of CD34(+) cells generated using hematopoietic colony-forming assays, and the multipotent mesenchymal properties of CD73(+) cells generated using in vitro differentiation assays. RESULTS: We observed that in the first 2 weeks of the hESC/OP9 coculture system CD34(+) hematopoietic and CD73(+) MSC generation follows a similar pattern. We sorted the CD34(+) cells and showed that they can generate hematopoietic progenitor colonies. Starting with cocultured cells on day 8, and through an enrichment procedure, we also could generate a pure population of MSCs. These hESC-derived MSCs had typical morphological and cell surface marker characteristics of adult bone marrow-derived MSCs, and could be differentiated toward osteogenic, adipogenic, and chondrogenic cells in vitro, a hallmark property of MSCs. CONCLUSIONS: OP9 cells when cocultured with hESCs support simultaneous generation of CD34(+) primitive hematopoietic cells and CD73(+) MSCs from hESCs.
Authors: Hiroki Tsukamoto; Petya Chernogorova; Korcan Ayata; Ulrike V Gerlach; Ankur Rughani; Jerry W Ritchey; Jayanthi Ganesan; Marie Follo; Robert Zeiser; Linda F Thompson; Marco Idzko Journal: Blood Date: 2012-01-18 Impact factor: 22.113
Authors: Tsaiwei Olee; Shawn P Grogan; Martin K Lotz; Clifford W Colwell; Darryl D D'Lima; Evan Y Snyder Journal: Tissue Eng Part A Date: 2013-10-19 Impact factor: 3.845
Authors: Erin A Kimbrel; Nicholas A Kouris; Gregory J Yavanian; Jianlin Chu; Yu Qin; Ann Chan; Ram P Singh; Deborah McCurdy; Lynn Gordon; Ralph D Levinson; Robert Lanza Journal: Stem Cells Dev Date: 2014-05-02 Impact factor: 3.272
Authors: Juha P Laurila; Lilja Laatikainen; Maria D Castellone; Parul Trivedi; Jari Heikkila; Ari Hinkkanen; Peiman Hematti; Mikko O Laukkanen Journal: Cytotherapy Date: 2009 Impact factor: 5.414
Authors: Yen Shun Chen; Rebecca A Pelekanos; Rebecca L Ellis; Rachel Horne; Ernst J Wolvetang; Nicholas M Fisk Journal: Stem Cells Transl Med Date: 2012-02-07 Impact factor: 6.940
Authors: Wenchuan Chen; Hongzhi Zhou; Michael D Weir; Minghui Tang; Chongyun Bao; Hockin H K Xu Journal: Tissue Eng Part A Date: 2013-01-28 Impact factor: 3.845